JPMorgan Chase & Co’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $740K | Sell |
164,055
-83,387
| -34% | -$376K | ﹤0.01% | 3879 |
|
2025
Q1 | $1.1M | Buy |
247,442
+149,782
| +153% | +$664K | ﹤0.01% | 3598 |
|
2024
Q4 | $765K | Buy |
97,660
+67,325
| +222% | +$527K | ﹤0.01% | 3945 |
|
2024
Q3 | $399K | Buy |
30,335
+2,854
| +10% | +$37.5K | ﹤0.01% | 4150 |
|
2024
Q2 | $332K | Sell |
27,481
-3,687
| -12% | -$44.5K | ﹤0.01% | 4040 |
|
2024
Q1 | $507K | Sell |
31,168
-10,196
| -25% | -$166K | ﹤0.01% | 3949 |
|
2023
Q4 | $282K | Buy |
41,364
+8,841
| +27% | +$60.3K | ﹤0.01% | 4216 |
|
2023
Q3 | $177K | Sell |
32,523
-6,000
| -16% | -$32.7K | ﹤0.01% | 4293 |
|
2023
Q2 | $262K | Sell |
38,523
-156,912
| -80% | -$1.07M | ﹤0.01% | 4132 |
|
2023
Q1 | $979K | Buy |
195,435
+162,752
| +498% | +$815K | ﹤0.01% | 3466 |
|
2022
Q4 | $160K | Sell |
32,683
-1,296
| -4% | -$6.35K | ﹤0.01% | 4305 |
|
2022
Q3 | $491K | Buy |
33,979
+1,315
| +4% | +$19K | ﹤0.01% | 3765 |
|
2022
Q2 | $494K | Sell |
32,664
-9,658
| -23% | -$146K | ﹤0.01% | 3876 |
|
2022
Q1 | $503K | Buy |
42,322
+4,752
| +13% | +$56.5K | ﹤0.01% | 3986 |
|
2021
Q4 | $610K | Buy |
37,570
+1,690
| +5% | +$27.4K | ﹤0.01% | 3952 |
|
2021
Q3 | $1.02M | Buy |
35,880
+461
| +1% | +$13.2K | ﹤0.01% | 3590 |
|
2021
Q2 | $1.2M | Buy |
35,419
+3,503
| +11% | +$118K | ﹤0.01% | 3538 |
|
2021
Q1 | $965K | Buy |
31,916
+1,909
| +6% | +$57.7K | ﹤0.01% | 3683 |
|
2020
Q4 | $1.49M | Buy |
30,007
+325
| +1% | +$16.1K | ﹤0.01% | 3155 |
|
2020
Q3 | $1.2M | Sell |
29,682
-1,754
| -6% | -$71K | ﹤0.01% | 3013 |
|
2020
Q2 | $1.36M | Sell |
31,436
-1,035
| -3% | -$44.7K | ﹤0.01% | 2870 |
|
2020
Q1 | $847K | Sell |
32,471
-1,762
| -5% | -$46K | ﹤0.01% | 3032 |
|
2019
Q4 | $1.07M | Sell |
34,233
-963
| -3% | -$30.1K | ﹤0.01% | 3032 |
|
2019
Q3 | $917K | Buy |
35,196
+2,007
| +6% | +$52.3K | ﹤0.01% | 3104 |
|
2019
Q2 | $739K | Buy |
33,189
+3,115
| +10% | +$69.4K | ﹤0.01% | 3192 |
|
2019
Q1 | $788K | Sell |
30,074
-1,249
| -4% | -$32.7K | ﹤0.01% | 3148 |
|
2018
Q4 | $637K | Buy |
31,323
+1,298
| +4% | +$26.4K | ﹤0.01% | 3271 |
|
2018
Q3 | $798K | Buy |
+30,025
| New | +$798K | ﹤0.01% | 3280 |
|